التفاصيل البيبلوغرافية
| العنوان: |
RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia. |
| المؤلفون: |
De, Chandrav, Pickles, Raymond J., Wenbo Yao, Baolin Liao, Boone, Allison, Cleary, Rachel A., Garcia, J. Victor, Wahl, Angela |
| المصدر: |
Frontiers in Virology; 2024, p01-10, 10p |
| مصطلحات موضوعية: |
RESPIRATORY syncytial virus infections, PATHOLOGICAL physiology, RESPIRATORY infections, BRONCHOPNEUMONIA, BRONCHIOLITIS, VENTILATION, YOUNG adults |
| مستخلص: |
Respiratory syncytial virus (RSV) is a substantial causeof severe lower respiratory tract infections in infants, young children, older adults, and immunocompromised individuals. There is a vital need for effective therapeutics to prevent and/or treat severe RSV infection in these high-risk individuals. The development and pre-clinical testing of candidate RSV therapeutics could be accelerated by their evaluation in animal models that recapitulate bronchiolitis and bronchopneumonia, both hallmark features of severe RSV infection in humans. Previously, we demonstrated that implanted human lung tissue in humanized lung-only mice (LoM) can be infected with RSV, resulting in sustained virus replication. Here we analyzed RSV-associated human lung pathology in the human lung implants of RSV-infected LoM. RSVinfected epithelial cells lining the airway and the alveolar regions of human lung implants result in hallmark histological features of RSV bronchiolitis and bronchopneumonia, including distal airway and alveolar lumens clogged with (1) sloughed and necrotic RSV-infected epithelial cells, (2) neutrophil-containing inflammatory infiltrates, and (3) MUC5B-dominated mucus secretions. We also show that treatment of LoM with a small molecule antiviral (ribavirin) or a neutralizing antibody (palivizumab) significantly suppressed and/or prevented RSV infection in vivo. Our data together show that RSV infection of human lung implants in vivo exhibits appropriate cellular tropism and results in the hallmark pathological characteristics of severe bronchiolitis and bronchopneumonia in humans. They also offer proof-of-principle of the utility of this model to evaluate novel approaches for the prevention/treatment of RSV infection. [ABSTRACT FROM AUTHOR] |
|
Copyright of Frontiers in Virology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder